Owings Mills, Md. – (June 4, 2009)
– Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today that it has relocated its corporate headquarters to Owings Mills in Baltimore County. Specializing in the support of best practices management of clinical trials, clinical cohort studies, case/control studies, clinical registries and laboratory studies, C-TASC now occupies 17,000 square-feet of office space at 10065 Red Run Boulevard – more than twice the size of its previous facility.
Formerly headquartered in Baltimore City, the move was necessary to accommodate the rapid expansion of the C-TASC staff, which has added more than 10 full-time employees within the last year. Currently a staff of 40, the company plans to continue to grow to at least 60 employees by February 2010.
This significant growth is a result of the increased demand for C-TASC’s clinical trials services and technologies. In 2008, C-TASC won numerous new contracts to coordinate multi-center clinical trials, including its current work with the National Institutes of Child Health and Human Services (NICHHD), New York University (NYU), Johns Hopkins University School of Medicine and the Food and Drug Administration (FDA).
Much of C-TASC’s recent success can be attributed to the development and utilization of its proprietary Web-based data management application suite, known as StudyCTMSTM, which enables investigators to easily develop and manage clinical studies and deliver the accumulated data and metadata in an easy-to-read and FDA-acceptable format.
“We have been very fortunate over the last year to be in the position to bring in new staff to support the many federal and private contracts that have been awarded to us, however as a result, we rapidly outgrew our previous office space,” said Dr. Bruce Thompson, president, C-TASC. “After evaluating many different sites, Owings Mills provided us with the best location to fit our current needs while leaving us room to continue to grow comfortably throughout 2009 and beyond.”
About C-TASC
Based near Baltimore, Clinical Trials & Surveys Corp. (C-TASC) is a clinical trials solutions company that has supported best practices management of clinical trials and studies for government, university and private organizations since 1989. C-TASC has a successful research history in cancer, cardiovascular disease, AIDS, pulmonary disease, Cystic Fibrosis, sleep disorders and pharmaco-epidemiology. C-TASC’s software group utilizes the firm’s StudyCTMSTM product suite to provide investigators with complete Web-based trial management designed to deliver FDA-acceptable data. The C-TASC professional services group provides expert consultation in all areas of clinical trial management including medical and statistical study design, project management, data conversion including FDA SDTM formatting, performance monitoring, data quality control and analysis as well as support for study publication and presentation. For more information about C-TASC’s projects, products and services, please visit
www.c-tasc.com
.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.